110 studies found for:    Chorea
Show Display Options
Rank Status Study
21 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
22 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
23 Completed Famotidine for Levodopa-induced Dyskinesia in PD
Condition: Dyskinesia
Intervention: Drug: Famotidine
24 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)
25 Terminated Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
Condition: Hyperkinetic Movement Disorders
Intervention: Drug: tetrabenazine
26 Completed Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
Conditions: Parkinson Disease;   Dyskinesias
Intervention: Drug: levodopa/carbidopa
27 Completed Comparative 2-D Tumor Analysis in Familial Gliomas
Condition: Malignant Glioma
Intervention:
28 Unknown  Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study
Condition: Dystonic Cerebral Palsy
Interventions: Drug: L- DOPA;   Drug: placebo
29 Completed Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
Conditions: Mental Disorder Diagnosed in Childhood;   Obsessive Compulsive Disorder;   Streptococcal Infection;   Tic Disorder
Intervention: Drug: Penicillin or Placebo
30 Recruiting Exploring Hypertonia in Children With Cerebral Palsy
Condition: Cerebral Palsy.
Intervention: Other: No intervention applicable
31 Completed Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: GSK356278;   Drug: Rolipram
32 Completed Riluzole in Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Riluzole
33 Recruiting REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Condition: Huntington Disease, Juvenile
Intervention:
34 Recruiting Walking While Talking: The Effect of Doing Two Things at Once in Individuals With Neurological Injury or Disease
Conditions: Parkinson's Disease;   Huntington's Disease;   Multiple Sclerosis;   Traumatic Brain Injury
Interventions: Behavioral: Gait-cognitive training;   Behavioral: Identification of at risk variables
35 Completed Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
Conditions: Alzheimer Disease;   Huntington Disease
Interventions: Drug: digoxin;   Drug: dimebon
36 Recruiting Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease
Condition: Huntington Disease
Intervention: Other: 31-Phosphorus RMN Spectroscopy
37 Completed
Has Results
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Condition: Huntington's Disease
Intervention:
38 Recruiting Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: OMS643762;   Drug: Placebo
39 Recruiting Effect of Tetrabenazine on Stroop Interference in HD
Condition: Huntington Disease
Intervention: Drug: Tetrabenazine withdrawal
40 Completed A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin
Conditions: Alzheimer's Disease;   Huntington's Disease
Interventions: Drug: Dimebon IR;   Drug: Dimebon Transdermal

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years